{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T12:11:08Z","timestamp":1782994268065,"version":"3.54.5"},"reference-count":64,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2013,3,14]],"date-time":"2013-03-14T00:00:00Z","timestamp":1363219200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0058955","type":"journal-article","created":{"date-parts":[[2013,3,14]],"date-time":"2013-03-14T23:45:33Z","timestamp":1363304733000},"page":"e58955","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":32,"title":["Serum Proteome Profiling Identifies Novel and Powerful Markers of Cystic Fibrosis Liver Disease"],"prefix":"10.1371","volume":"8","author":[{"given":"Timo","family":"Rath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Hage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"K\u00fcgler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Menendez Menendez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhart","family":"Zachoval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lutz","family":"Naehrlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Roderfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Roeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,3,14]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1002\/hep.1840360613","article-title":"Liver disease in cystic fibrosis: A prospective study on incidence, risk factors, and outcome","volume":"36","author":"C Colombo","year":"2002","journal-title":"Hepatology"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.510300527","article-title":"Natural history of liver disease in cystic fibrosis","volume":"30","author":"A Lindblad","year":"1999","journal-title":"Hepatology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/MOG.0b013e3283298865","article-title":"Hepatobiliary disease in patients with cystic fibrosis","volume":"25","author":"K Moyer","year":"2009","journal-title":"Curr Opin Gastroenterol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/S1569-1993(11)60006-4","article-title":"Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease","volume":"10","author":"D Debray","year":"2011","journal-title":"J Cyst Fibros"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/00005176-199900001-00001","article-title":"Recommendations for management of liver and biliary tract disease in cystic fibrosis. Cystic Fibrosis Foundation Hepatobiliary Disease Consensus Group","volume":"28","author":"RJ Sokol","year":"1999","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref6","first-page":"1449","article-title":"Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology","volume":"38","author":"P Bedossa","year":"2003"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0168-8278(03)00191-0","article-title":"Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease","volume":"39","author":"G Colloredo","year":"2003","journal-title":"J Hepatol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1111\/j.1572-0241.2002.06038.x","article-title":"Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection","volume":"97","author":"A Regev","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1056\/NEJM200102153440706","article-title":"Liver biopsy","volume":"344","author":"AA Bravo","year":"2001","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1053\/jhep.2000.16602","article-title":"Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF)","volume":"32","author":"JF Cadranel","year":"2000","journal-title":"Hepatology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1002\/hep.510300624","article-title":"Pain experienced during percutaneous liver biopsy","volume":"30","author":"L Castera","year":"1999","journal-title":"Hepatology"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Malbrunot-Wagner AC, Bridoux L, Nousbaum JB, Riou C, Dirou A, <etal>et al<\/etal>.. (2011) Transient elastography and portal hypertension in pediatric patients with cystic fibrosis Transient elastography and cystic fibrosis. J Cyst Fibros.","DOI":"10.1016\/j.jcf.2011.04.004"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jcf.2009.08.001","article-title":"Non-invasive liver elastography (Fibroscan) for detection of cystic fibrosis-associated liver disease","volume":"8","author":"P Witters","year":"2009","journal-title":"J Cyst Fibros"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.dld.2012.04.008","article-title":"TIMP-1\/-2 and transient elastography allow non invasive diagnosis of cystic fibrosis associated liver disease","volume":"44","author":"T Rath","year":"2012","journal-title":"Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.3748\/wjg.15.2433","article-title":"Non-invasive biomarkers for monitoring the fibrogenic process in liver: a short survey","volume":"15","author":"AM Gressner","year":"2009","journal-title":"World J Gastroenterol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.3109\/00365521.2011.613949","article-title":"YKL-40 and transient elastography, a powerful team to assess hepatic fibrosis","volume":"46","author":"T Rath","year":"2011","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1164\/rccm.200705-664OC","article-title":"Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health","volume":"176","author":"PA Flume","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jcf.2004.12.002","article-title":"Standards of care for patients with cystic fibrosis: a European consensus","volume":"4","author":"E Kerem","year":"2005","journal-title":"J Cyst Fibros"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","article-title":"Statistical methods for assessing agreement between two methods of clinical measurement","volume":"1","author":"JM Bland","year":"1986","journal-title":"Lancet"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1007\/s00247-009-1531-z","article-title":"Transient elastography in patients with cystic fibrosis","volume":"40","author":"R Menten","year":"2010","journal-title":"Pediatric radiology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"e42139","DOI":"10.1371\/journal.pone.0042139","article-title":"Non-invasive evaluation of cystic fibrosis related liver disease in adults with ARFI, transient elastography and different fibrosis scores","volume":"7","author":"T Karlas","year":"2012","journal-title":"PloS one"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0022-3476(94)70301-9","article-title":"Outcome measures for clinical trials in cystic fibrosis. Summary of a Cystic Fibrosis Foundation consensus conference","volume":"124","author":"BW Ramsey","year":"1994","journal-title":"The Journal of pediatrics"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jcf.2004.12.002","article-title":"Standards of care for patients with cystic fibrosis: a European consensus","volume":"4","author":"E Kerem","year":"2005","journal-title":"Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/00001577-200214030-00006","article-title":"Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis","volume":"14","author":"R Gault","year":"2002","journal-title":"Pediatric physical therapy : the official publication of the Section on Pediatrics of the American Physical Therapy Association"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1471-230X-11-91","article-title":"Non-invasive markers for hepatic fibrosis","volume":"11","author":"A Baranova","year":"2011","journal-title":"BMC gastroenterology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.bpg.2011.02.003","article-title":"Invasive and non-invasive methods for the assessment of fibrosis and disease progression in chronic liver disease","volume":"25","author":"L Castera","year":"2011","journal-title":"Best practice & research Clinical gastroenterology"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1097\/01.mpg.0000226390.02355.52","article-title":"Liver disease in cystic fibrosis","volume":"43","author":"C Colombo","year":"2006","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.bpg.2010.08.003","article-title":"Cystic fibrosis-associated liver disease","volume":"24","author":"U Herrmann","year":"2010","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"ref29","first-page":"1005","article-title":"[Value of transient elastography in noninvasive assessment in children&apos;s hepatic fibrosis]","volume":"16","author":"E Breton","year":"2009","journal-title":"Arch Pediatr"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0140-6736(08)60383-9","article-title":"Liver cirrhosis","volume":"371","author":"D Schuppan","year":"2008","journal-title":"Lancet"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1053\/jhep.2001.28457","article-title":"Transforming growth factor beta and the liver","volume":"34","author":"DM Bissell","year":"2001","journal-title":"Hepatology"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"d793","DOI":"10.2741\/A812","article-title":"Roles of TGF-beta in hepatic fibrosis","volume":"7","author":"AM Gressner","year":"2002","journal-title":"Frontiers in bioscience : a journal and virtual library"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.mrrev.2006.07.002","article-title":"The activin axis in liver biology and disease","volume":"613","author":"C Rodgarkia-Dara","year":"2006","journal-title":"Mutation research"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0168-8278(99)80351-1","article-title":"Increased expression of plasminogen activator and plasminogen activator inhibitor during liver fibrogenesis of rats: role of stellate cells","volume":"31","author":"LP Zhang","year":"1999","journal-title":"Journal of hepatology"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.cyto.2011.03.001","article-title":"High plasma fractalkine (CX3CL1) levels are associated with severe liver disease in HIV\/HCV co-infected patients with HCV genotype 1","volume":"54","author":"M Garcia-Alvarez","year":"2011","journal-title":"Cytokine"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jhep.2007.02.003","article-title":"Expression of MMPs and TIMPs in liver fibrosis - a systematic review with special emphasis on anti-fibrotic strategies","volume":"46","author":"S Hemmann","year":"2007","journal-title":"Journal of hepatology"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0168-8278(97)80359-5","article-title":"TIMP expression in toxic and cholestatic liver injury in rat","volume":"27","author":"E Roeb","year":"1997","journal-title":"J Hepatol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1053\/gast.1996.v110.pm8608892","article-title":"Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver","volume":"110","author":"RC Benyon","year":"1996","journal-title":"Gastroenterology"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0168-8278(99)80101-9","article-title":"Spatial distribution of tissue inhibitor of metalloproteinase-1 mRNA in chronic liver disease","volume":"30","author":"Y Yata","year":"1999","journal-title":"J Hepatol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1042\/CS20030098","article-title":"Expression and coordinated regulation of matrix metalloproteinases in chronic hepatitis C and hepatitis C virus-induced liver cirrhosis","volume":"105","author":"R Lichtinghagen","year":"2003","journal-title":"Clin Sci (Lond)"},{"key":"ref41","first-page":"812","article-title":"Tissue inhibitors of metalloproteinases in liver and serum\/plasma in chronic active hepatitis C and HCV-induced cirrhosis","volume":"47","author":"KH Boker","year":"2000","journal-title":"Hepatogastroenterology"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.jss.2009.10.038","article-title":"Differential expression of hepatic fibrosis mediators in sick and spontaneously recovered mice with experimental biliary atresia","volume":"159","author":"EP Nadler","year":"2010","journal-title":"The Journal of surgical research"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1053\/j.gastro.2004.08.052","article-title":"Serum markers detect the presence of liver fibrosis: a cohort study","volume":"127","author":"WM Rosenberg","year":"2004","journal-title":"Gastroenterology"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.jhep.2004.08.008","article-title":"Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients","volume":"41","author":"K Patel","year":"2004","journal-title":"Journal of hepatology"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1006\/bbrc.2001.4526","article-title":"Endoglin expression in human and rat mesangial cells and its upregulation by TGF-beta1","volume":"282","author":"A Rodriguez-Barbero","year":"2001","journal-title":"Biochemical and biophysical research communications"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1074\/jbc.M405411200","article-title":"Identification of endoglin in rat hepatic stellate cells: new insights into transforming growth factor beta receptor signaling","volume":"280","author":"SK Meurer","year":"2005","journal-title":"The Journal of biological chemistry"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1002\/art.10333","article-title":"Dysregulation of transforming growth factor beta signaling in scleroderma: overexpression of endoglin in cutaneous scleroderma fibroblasts","volume":"46","author":"A Leask","year":"2002","journal-title":"Arthritis and rheumatism"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1161\/01.RES.0000150369.68826.2f","article-title":"Transforming growth factor beta receptor endoglin is expressed in cardiac fibroblasts and modulates profibrogenic actions of angiotensin II","volume":"95","author":"K Chen","year":"2004","journal-title":"Circulation research"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.cellsig.2010.12.002","article-title":"Expression and functional analysis of endoglin in isolated liver cells and its involvement in fibrogenic Smad signalling","volume":"23","author":"SK Meurer","year":"2011","journal-title":"Cellular signalling"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/MEG.0b013e3282202bea","article-title":"Elevation of endoglin (CD105) concentrations in serum of patients with liver cirrhosis and carcinoma","volume":"19","author":"E Yagmur","year":"2007","journal-title":"European journal of gastroenterology & hepatology"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1365-2893.2006.00733.x","article-title":"Increased intrahepatic and circulating levels of endoglin, a TGF-beta1 co-receptor, in patients with chronic hepatitis C virus infection: relationship to histological and serum markers of hepatic fibrosis","volume":"13","author":"M Clemente","year":"2006","journal-title":"Journal of viral hepatitis"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/342440a0","article-title":"Molecular cloning and expression of human hepatocyte growth factor","volume":"342","author":"T Nakamura","year":"1989","journal-title":"Nature"},{"key":"ref53","first-page":"223","article-title":"Evaluation of serum concentrations of human hepatocyte growth factor during interferon therapy for chronic hepatitis C. Intervirology","volume":"48","author":"M Moriyama","year":"2005"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000050028","article-title":"Detection of serum and intrahepatic human hepatocyte growth factor in patients with type C liver diseases","volume":"44","author":"H Yamagami","year":"2001","journal-title":"Intervirology"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/hep.1840210119","article-title":"Serum hepatocyte growth factor levels in liver diseases: clinical implications","volume":"21","author":"G Shiota","year":"1995","journal-title":"Hepatology"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0140-6736(92)92396-W","article-title":"Prediction of outcome in fulminant hepatic failure by serum human hepatocyte growth factor","volume":"340","author":"H Tsubouchi","year":"1992","journal-title":"Lancet"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s10096-010-1149-y","article-title":"Twelve potential fibrosis markers to differentiate mild liver fibrosis from cirrhosis in patients infected with chronic hepatitis C genotype 1","volume":"30","author":"ES Andersen","year":"2011","journal-title":"European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.coi.2005.11.009","article-title":"Pentraxins as a key component of innate immunity","volume":"18","author":"B Bottazzi","year":"2006","journal-title":"Current opinion in immunology"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1146\/annurev.immunol.23.021704.115756","article-title":"Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility","volume":"23","author":"C Garlanda","year":"2005","journal-title":"Annual review of immunology"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1002\/1529-0131(200112)44:12<2841::AID-ART472>3.0.CO;2-6","article-title":"PTX3 in small-vessel vasculitides: an independent indicator of disease activity produced at sites of inflammation","volume":"44","author":"F Fazzini","year":"2001","journal-title":"Arthritis and rheumatism"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1161\/01.CIR.102.6.636","article-title":"PTX3, A prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans","volume":"102","author":"G Peri","year":"2000","journal-title":"Circulation"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1161\/01.CIR.0000145167.30987.2E","article-title":"Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction","volume":"110","author":"R Latini","year":"2004","journal-title":"Circulation"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1086\/322035","article-title":"Local interferon-gamma levels during respiratory syncytial virus lower respiratory tract infection are associated with disease severity","volume":"184","author":"L Bont","year":"2001","journal-title":"The Journal of infectious diseases"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1471-230X-8-53","article-title":"Plasma Pentraxin3 is a novel marker for nonalcoholic steatohepatitis (NASH)","volume":"8","author":"M Yoneda","year":"2008","journal-title":"BMC gastroenterology"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0058955","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T22:21:22Z","timestamp":1588976482000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0058955"}},"subtitle":[],"editor":[{"given":"Dominik","family":"Hartl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,3,14]]},"references-count":64,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2013,3,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0058955","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,14]]}}}